Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials

NCT06361056 | Completed DMC

• 1 other identifier: LCCC2140
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This study explores the overall feasibility, impact, and satisfaction of using the "mHealth app" on clinic workflow for Black or African American women diagnosed with breast cancer. The "mHealth app" which can be used as a platform to share clinical trial education and communication, was created and tested in previous steps of this study.

Conditions

Breast Cancer

Keywords

application; mHealth

Outcome Measures

Primary Outcomes (2)

• Feasibility of Mobile Health Application (mHealth app)- subjects

  The feasibility of the mHealth app will be determined by the percentage of subjects who enrolled and completed trial requirements.

  Up to 1 year

• Feasibility of Mobile Health Application (mHealth app) - Clinicians and staff

  Clinicians and staff will be interviewed to assess feasibility.

  Up to 1 year

Secondary Outcomes (1)

• Overall satisfaction

  Up to 1 year

Study Arms (1)

mHealth app

EXPERIMENTAL

Women enrolled in the mHealth app study will receive access to the "mHealth" app, a list of available clinical trials within a 50-mile radius of their zip code, and the existing standard of care packet of cancer center resources.

Behavioral: Survey; Behavioral: mHealth app

Interventions

Survey BEHAVIORAL

All participants will complete a brief questionnaire.

Also known as: Questionnaire

mHealth app

mHealth app BEHAVIORAL

Eighty Black women with newly diagnosed breast cancer (inclusive of all stages) and who have access to a mobile device or computer will be recruited to the study intervention.

mHealth app

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: Participants are women with breast cancer
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older
• English speaking
• Able and willing to participate to complete the survey.
• Have access to a mobile device or computer.
• Diagnosed with breast cancer.
• Identify as African American

You may not qualify if:

• Inability to read and speak English.
• Dementia altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent.

Sponsors & Collaborators

• UNC Lineberger Comprehensive Cancer Center: lead
• Conquer Cancer Foundation: collaborator

Study Sites (1)

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27514, United States

Location

Related Links

• University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Marjory Charlot, MD, MPH, MSc

  UNC Lineberger Comprehensive Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 22, 2024
• First Posted: April 11, 2024
• Study Start: May 2, 2022
• Primary Completion: July 26, 2025
• Study Completion: November 20, 2025
• Last Updated: February 12, 2026

Record last verified: 2026-02

Locations

US (1)